Birdwatch Note
2023-10-02 19:04:15 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin has efficacy in treating parasitic infections. Ivermectin has no efficacy to treat COVID-19 based on randomized controlled trials. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662 Ivermectin has only shown success in COVID-19 treatment in studies from countries with high rates of parasitic infections. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790173
Written by 126B08F48F0E9CE041213ED973F0E0237B12EC0F8213AB393E2E2981CD04B5D5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1708901143181427002
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1708920849997197674
- noteId - 1708920849997197674
- participantId -
- noteAuthorParticipantId - 126B08F48F0E9CE041213ED973F0E0237B12EC0F8213AB393E2E2981CD04B5D5 Participant Details
- createdAtMillis - 1696273455507
- tweetId - 1708901143181427002
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin has efficacy in treating parasitic infections. Ivermectin has no efficacy to treat COVID-19 based on randomized controlled trials. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662 Ivermectin has only shown success in COVID-19 treatment in studies from countries with high rates of parasitic infections. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790173
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-10-02 19:04:15 UTC (1696273455507) |
1969-12-31 23:59:59 UTC (-1) |
2023-10-03 02:49:27 UTC (1696301367088) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-10-02 19:17:47 -0500 | Rating Details | |
| 2023-10-02 19:13:02 -0500 | Rating Details | |
| 2023-10-02 18:55:21 -0500 | Rating Details | |
| 2023-10-02 18:41:52 -0500 | Rating Details | |
| 2023-10-02 17:50:20 -0500 | Rating Details | |
| 2023-10-02 17:40:51 -0500 | Rating Details | |
| 2023-10-02 17:19:06 -0500 | Rating Details | |
| 2023-10-02 17:17:12 -0500 | Rating Details | |
| 2023-10-02 17:09:33 -0500 | Rating Details | |
| 2023-10-02 17:07:02 -0500 | Rating Details | |
| 2023-10-02 17:01:48 -0500 | Rating Details | |
| 2023-10-02 17:01:01 -0500 | Rating Details | |
| 2023-10-02 16:35:03 -0500 | Rating Details | |
| 2023-10-02 16:30:26 -0500 | Rating Details | |
| 2023-10-02 16:29:11 -0500 | Rating Details | |
| 2023-10-02 16:28:14 -0500 | Rating Details | |
| 2023-10-02 16:25:20 -0500 | Rating Details | |
| 2023-10-02 16:15:07 -0500 | Rating Details | |
| 2023-10-02 15:57:53 -0500 | Rating Details | |
| 2023-10-02 15:56:52 -0500 | Rating Details | |
| 2023-10-02 15:56:08 -0500 | Rating Details | |
| 2023-10-02 15:55:14 -0500 | Rating Details | |
| 2023-10-02 15:46:15 -0500 | Rating Details | |
| 2023-10-02 15:44:32 -0500 | Rating Details | |
| 2023-10-02 15:44:10 -0500 | Rating Details | |
| 2023-10-02 15:42:00 -0500 | Rating Details | |
| 2023-10-02 15:30:43 -0500 | Rating Details | |
| 2023-10-02 15:18:43 -0500 | Rating Details | |
| 2023-10-02 15:02:19 -0500 | Rating Details | |
| 2023-10-02 15:00:04 -0500 | Rating Details | |
| 2023-10-02 14:47:21 -0500 | Rating Details | |
| 2023-10-02 14:27:21 -0500 | Rating Details | |
| 2023-10-02 14:15:34 -0500 | Rating Details | |
| 2023-10-02 14:13:15 -0500 | Rating Details | |
| 2023-10-02 14:13:08 -0500 | Rating Details | |
| 2023-10-02 14:05:43 -0500 | Rating Details | |
| 2023-10-02 14:05:00 -0500 | Rating Details | |
| 2023-10-03 12:27:45 -0500 | Rating Details | |
| 2023-10-03 11:32:52 -0500 | Rating Details | |
| 2023-10-03 11:15:45 -0500 | Rating Details | |
| 2023-10-03 10:43:51 -0500 | Rating Details | |
| 2023-10-03 10:27:43 -0500 | Rating Details | |
| 2023-10-03 10:17:04 -0500 | Rating Details | |
| 2023-10-03 09:48:49 -0500 | Rating Details | |
| 2023-10-03 07:01:00 -0500 | Rating Details | |
| 2023-10-03 06:27:44 -0500 | Rating Details | |
| 2023-10-03 05:45:44 -0500 | Rating Details | |
| 2023-10-03 04:08:16 -0500 | Rating Details | |
| 2023-10-03 03:26:51 -0500 | Rating Details | |
| 2023-10-03 02:23:38 -0500 | Rating Details | |
| 2023-10-03 01:52:28 -0500 | Rating Details | |
| 2023-10-03 01:34:54 -0500 | Rating Details | |
| 2023-10-03 01:31:41 -0500 | Rating Details | |
| 2023-10-03 00:55:58 -0500 | Rating Details | |
| 2023-10-03 00:25:15 -0500 | Rating Details | |
| 2023-10-03 00:22:19 -0500 | Rating Details | |
| 2023-10-02 23:26:22 -0500 | Rating Details | |
| 2023-10-02 23:05:30 -0500 | Rating Details | |
| 2023-10-02 22:46:48 -0500 | Rating Details | |
| 2023-10-02 22:36:16 -0500 | Rating Details | |
| 2023-10-02 22:03:39 -0500 | Rating Details | |
| 2023-10-02 21:29:49 -0500 | Rating Details | |
| 2023-10-02 20:17:07 -0500 | Rating Details | |
| 2023-10-02 20:15:22 -0500 | Rating Details | |
| 2023-10-04 17:34:03 -0500 | Rating Details | |
| 2023-10-04 09:36:29 -0500 | Rating Details | |
| 2023-10-04 06:46:28 -0500 | Rating Details | |
| 2023-10-04 06:29:10 -0500 | Rating Details | |
| 2023-10-04 05:28:30 -0500 | Rating Details | |
| 2023-10-03 22:58:20 -0500 | Rating Details | |
| 2023-10-03 22:23:53 -0500 | Rating Details | |
| 2023-10-05 17:00:45 -0500 | Rating Details |